CytoDyn (CYDY)
OTHER OTC:CYDY
Holding CYDY?
Track your performance easily

CytoDyn (CYDY) Income Statement

634 Followers

CytoDyn Income Statement

Last quarter (Q ), CytoDyn's total revenue was $―, a decrease of ― from the same quarter last year. In Q, CytoDyn's net income was $-18.27M. See CytoDyn’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
May 24May 23May 22May 21May 20
Total Revenue
---$ 300.00K$ 0.00$ 0.00
Cost of Revenue
--$ 20.63M$ -53.00K--
Gross Profit
--$ -20.63M$ 213.00K--
Operating Expense
$ 19.71M$ 19.71M$ 31.82M$ 75.17M$ 94.55M$ 74.65M
Operating Income
$ -18.06M$ -18.06M$ -40.58M$ -148.43M$ -94.55M$ -74.65M
Net Non Operating Interest Income Expense
$ -4.66M$ -4.66M$ -22.75M$ -50.26M$ -19.55M$ -18.21M
Other Income Expense
$ 13.37M$ 13.37M-$ 6.69M$ -40.57M$ -31.54M
Pretax Income
$ -49.80M$ -49.80M$ -79.82M$ -210.82M$ -154.67M$ -124.40M
Tax Provision
----$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -51.32M$ -51.32M$ -79.82M$ -210.80M$ -154.67M$ -124.40M
Basic EPS
$ -0.08$ -0.05$ -0.10$ -0.31$ -0.27$ -0.30
Diluted EPS
$ -0.08$ -0.05$ -0.10$ -0.31$ -0.27$ -0.30
Basic Average Shares
$ 3.88B$ 969.51M$ 836.53M$ 676.90M$ 587.59M$ 421.08M
Diluted Average Shares
$ 3.88B$ 969.51M$ 836.53M$ 676.90M$ 587.59M$ 421.08M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 19.71M$ 19.71M$ 52.45M$ 75.22M$ 94.55M$ 74.65M
Net Income From Continuing And Discontinued Operation
$ -49.84M$ -49.84M$ -79.82M$ -210.80M$ -154.67M$ -124.40M
Normalized Income
$ -41.66M$ -39.34M--$ -114.10M$ -92.36M
Interest Expense
----$ 19.34M$ 16.88M
EBIT
$ -39.21M$ -45.18M$ -52.45M$ -160.56M$ -135.33M$ -107.52M
EBITDA
$ -37.53M$ -43.51M$ -40.40M$ -156.73M$ -133.53M$ -105.49M
Currency in USD

CytoDyn Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis